does glp 1 increase risk of cancer Semaglutide: What we know about safety and GLP-1s in Oncology: Exploring Risks

In general, eating less affects how often and when you have bowel movements

The commentary authors added that some of the new study's results appear to contradict other research

Statistics indicate that roughly 7.2 million people in the UK live with CKD, and a significant proportion of these individuals face the added metabolic burden of excess weight

If small-molecule chemistry can produce an oral GLP-1 agonist (orforglipron), can it also produce oral molecules that activate multiple metabolic receptors simultaneously

But recent studies suggest that many patients who discontinue these drugs after achieving their weight loss results are regaining nearly two-thirds of their lost pounds